Categories LATEST

DropCar crashes 30% on offering announcement

Shares of DropCar (DCAR), which offers an automated platform for pick-up and delivery of vehicles for maintenance and service, saw its stock slide over 30% on Wednesday. The sell-off was spurred by investors who panicked after the company said in an SEC filing that it would issue and sell 478,469 shares of its common stock, par value $0.0001 per share, at an offering price of $4.18 per share for gross proceeds of about $2 million.

DCAR stock has more-than-tripled so far this year. This comes as a slight respite after the stock lost 65% of its value in trailing 52 weeks.

The New York City-based firm grew its top line by 405% last year, but many investors are reluctant to bet on this stock that been seeing mounting losses. Meanwhile, bullish investors expect the company to rebound once ride-hailing service Lyft goes public next month.

drop car stock tumble
Photo by Andre Iv on Unsplash

READ: BMW’S PROFIT WARNING SENDS SHOCKWAVES THROUGH THE US AUTO INDUSTRY

Earlier this month, CEO Spencer Richardson had announced that the company was exploring strategic alternatives, including a potential sale to maximize shareholder value. A stock sale is also likely to lift DropCar’s stock in the coming months.

On March 8, the company launched a 1:6 reverse stock split after its share price fell below $1, to regain Nasdaq compliance.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Also Read:  Partnerships likely to drive Dropbox higher post Q2

Most Popular

BlackBerry (BB) likely to report weak Q4 earnings on March 31

BlackBerry Limited (NYSE: BB) is slated to report its fourth-quarter 2020 earnings results on Tuesday, March 31, after the market closes. The top line will be benefited by BlackBerry Cylance

Companies that are working on the coronavirus vaccine

The coronavirus pandemic continues to plague the world with over 500,000 cases reported globally and over 82,000 cases in the US alone. As the world grapples with the outbreak, several

Altimmune (ALT) reports FY19 results; announces vaccine candidate for COVID-19

Altimmune Inc. (NASDAQ: ALT) reported its earnings results for fiscal-year 2019. Revenues totaled $5.8 million compared to $10.3 million last year. The drop in revenues was caused by lower billings